Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000929211 | SCV001074836 | likely benign | Tuberous sclerosis 2 | 2024-08-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001020962 | SCV001182513 | likely benign | Hereditary cancer-predisposing syndrome | 2018-04-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000929211 | SCV002039363 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004803311 | SCV005427197 | likely benign | Tuberous sclerosis syndrome | 2024-03-05 | criteria provided, single submitter | clinical testing |